Analysis: the fourth raise in four months, priced well under the market

The sequence in the dilution table is the most informative disclosure in the package. Counting this transaction, the company has completed four equity issuances between late May and late August 2026, three of them for cash of about US$2,000,000 or less each. The pattern disclosed is a sequence of small issuances rather than one financing. The last annual report, for the year ended March 31, 2026, shows cash and cash equivalents of approximately US$964,142, total shareholders’ equity of approximately US$3,284,813 and a net loss of approximately US$10,315,204.

The pricing is the second point. Shares were sold at US$1.00 against a last reported sale price of US$1.80 the previous day, a discount of nearly half. Registered directs to institutions commonly price below the market, and a best-efforts placement with no minimum gives the agent no obligation to fill the book, both of which push the clearing price down. The size of this particular gap is what stands out, and the company’s own float calculation, struck at US$2.96 using the highest closing price of July 13, 2026, sits above both figures.

The share price history frames the raise more sharply than any commentary could. A 52 week range of US$107.50 to US$1.58, split-adjusted, on a stock that consolidated ten to one in May, describes a share count expanding while the price falls. The pre-funded warrant structure adds a detail worth noting: a buyer subscribes for warrants rather than shares at closing and exercises later for a nominal US$0.001. Section 13(d) of the Securities Exchange Act, at 15 U.S.C. 78m(d), requires a beneficial owner of more than 5 per centum of a registered class of equity securities to file a disclosure statement with the Commission, and shares underlying unexercised pre-funded warrants are not held at closing. The company reports they have already been exercised, so the full 2,500,000 shares are outstanding.

Against the announced purpose, the sums are stated. Approximately 50% of approximately US$2.09 million in net proceeds is earmarked for potential strategic investment and acquisitions, and the company has separately announced a robotics development programme with a partner planning production of commercial service robots. The shelf, and the I.B.5. ceiling on it, set the capacity beyond this single transaction.

What is established here is narrow and factual: the amount raised, the price, the structure, the fees taken out and the stated use. What is not established is whether this financing completes anything. The disclosures to watch are the next prospectus supplement off the same shelf, the share count on the next reported balance sheet, and whether the strategic investment portion is deployed into a named transaction or absorbed into working capital.

What the documents say

Mint Incorporation Limited (NASDAQ: MIMI), a Hong Kong interior fit-out contractor now describing itself as focused on artificial intelligence and robotics, priced a registered direct offering on August 27, 2026 and closed it the following day. The company raised approximately US$2.5 million in gross proceeds at US$1.00 per share.

The pricing announcement described securities purchase agreements with certain institutional investors for an aggregate of 2,500,000 Class A ordinary shares with no par value, or pre-funded warrants in lieu of shares. The closing announcement sets out how the split actually fell: 1,400,000 Class A ordinary shares at US$1.00 each, and pre-funded warrants over 1,100,000 shares at US$0.999 each, priced at the share price less the US$0.001 per share exercise price. The company says the pre-funded warrants have been fully exercised. Maxim Group LLC acted as sole placement agent, on a best-efforts basis.

The shelf it came off

The offering was made under the company’s registration statement on Form F-3, File No. 333-296027, which the Securities and Exchange Commission declared effective on June 3, 2026, with a prospectus supplement filed for the transaction.

That supplement contains the figures the press releases omit. Net proceeds are stated as approximately US$2.09 million after placement agent fees and offering expenses, and the company intends to use approximately 50% for potential strategic investment and acquisitions and approximately 50% for working capital and general corporate purposes, with management given significant flexibility in applying them.

The supplement also states the public float. The aggregate market value of Class A ordinary shares held by non-affiliates was approximately US$36,567,549.92, calculated on 12,353,902 Class A ordinary shares held by non-affiliates at US$2.96 per share, the highest closing price on Nasdaq on July 13, 2026. Because that value is below US$75,000,000, General Instruction I.B.5 of Form F-3 caps primary sales at one third of it in any 12 month period.

Price history and the reverse split

The prospectus supplement records that the last reported sale price of the Class A ordinary shares on Nasdaq was US$1.80 on August 26, 2026, the day before pricing. It also states that in the year before the supplement, the high and low closing prices were US$107.50 and US$1.58 per Class A ordinary share, in each case adjusted for a share consolidation.

That consolidation was a 1-for-10 reverse stock split of both the Class A and Class B ordinary shares, approved by the board on March 31, 2026 and effective May 6, 2026. All share figures in the supplement are on a post-split basis. The company acknowledges in its own risk language that it has recently experienced price volatility.

Dilution, as the company calculates it

The supplement quantifies the effect on book value. Net tangible book value per Class A ordinary share before the offering was US$0.610. The offering adds US$0.037 per share, giving an as adjusted net tangible book value of US$0.647 per share as of March 31, 2026, or US$9.83 million in total. A buyer paying US$1.00 therefore takes an immediate dilution of US$0.353 per share, and a pre-funded warrant holder takes the same, since US$0.999 plus the US$0.001 exercise price equals the US$1.00 offering price.

The as adjusted figure also folds in three earlier issuances completed in 2026: 211,879 Class B ordinary shares on May 26, 2026 for net proceeds of US$637,755.10; 4,310,350 Class A ordinary shares on July 8, 2026 for net proceeds of US$2,000,000; and 6,329,115 Class A ordinary shares on August 11, 2026 for net proceeds of US$2,000,000.